Terbitac 1% (Cream)
10 gm tube: ৳ 70.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Terbinafine hydrochloride |
| Company | Ziska pharmaceuticals ltd |
| Also available as |
Title
- Terbitac Tablet
- Terbitac Granules
- Terbitac Cream
- Terbitac 1% Spray
Categories
- Antifungal Medications
- Topical Antifungal Products
Description
- Terbitac tablet is indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium).
- Terbitac granules are indicated in Tinea Capitis.
- Terbitac cream is indicated for fungal infection of the skin caused by various fungi.
- Terbitac 1% Spray is indicated in the treatment of tinea infections of the skin.
Dimensions
- Tablet size: 250 mg
- Granules: Available in 125 mg, 187.5 mg, 250 mg
- Cream: Available in standard cream tube size
- Spray: Available in standard spray bottle size
Color options
- Cream: White
- Spray: Transparent liquid
Functions
- Inhibits biosynthesis of Ergosterol
- Fungicidal against dermatophytes
- Treats onychomycosis and tinea infections of the skin
- Reduces membrane permeability
Materials
- Active ingredient: Terbinafine
- Tablet and Cream Base: Pharmaceutical grade ingredients
- Spray Solution: Pharmaceutical grade components
Technical specifications
- Inhibitor of the CYP450 2D6 isozyme
- Presence in breast milk of nursing mothers after oral administration
- Recommended storage temperature: Below 30°C
Design elements
- External use only for cream and spray
- Tablet to be taken orally
Usability features
- Tablet dosage: Once daily for 6 to 12 weeks, depending on infection location
- Granules dosage: Based on body weight
- Cream application: Once or twice daily, thin layer to affected areas
- Spray application: Once or twice daily, sufficient amount to wet treatment area
Interactions
- Inhibitor of the CYP450 2D6 isozyme
- May require reduction in dose of 2D6-metabolized drugs
Contraindications
- Contra-indicated in individuals hypersensitive to terbinafine
Side effects
- Gastrointestinal symptoms
- Liver test abnormalities
- Rashes
- Urticaria
- Pruritus
- Taste disturbances
- Idiosyncratic and symptomatic hepatic injury
- Serious skin reactions
- Severe neutropenia
- Thrombocytopenia
- Angioedema
- Allergic reactions
- Malaise
- Fatigue
- Vomiting
- Arthralgia
- Myalgia
- Hair loss
Pregnancy and lactation
- Not recommended during pregnancy
- Excreted in breast milk, not recommended during breastfeeding
Precautions and warnings
- Precautions for patients with chronic or active liver disease
- Discontinue treatment if there is evidence of liver injury
- Avoid contact with eyes for cream
Special populations use
- Safety and efficacy not established in pediatric patients
- No evidence of different dosage requirement for elderly patients
Overdose effects
- Limited clinical experience with overdose
- Symptoms may include nausea, vomiting, abdominal pain, and dizziness
Therapeutic class
- Antifungal preparations
Storage conditions
- Store in a cool and dry place, below 30°C, protect from light